Health
New tool can provide non-invasive decision support for NSCLC treatment – News-Medical.net
Personalized treatment options for patients with lung cancer have come a long way in the past two decades.
Reviewed by Emily Henderson, B.Sc.Oct 16 2020
Personalized treatment options for patients with lung cancer have come a long way in the past two decades. For patients with non-small cell lung cancer, the most common subtype of lung cancer and the leading cause of cancer-related death worldwide, two major treatment strategies have emerged: tyrosine kinase inhibitors and immune checkpoint inhibitors. However, choosing the right therapy for a non-small cell lung cancer patient isn’t always an easy …
-
Noosa News23 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News21 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
Business8 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General17 hours ago‘Potential’ hacker contacts Qantas over data breach